ARMCX1 and neoplasm: The higher total points, the lower survival rate, and the results substantiated that high expression levels of ARMCX1 and ARMCX2, age of the patient (>60 years old), and advanced tumor stage established a prognostic feature that conduced to the highest risk for poor OS (Figure 6).